Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation

Arthritis Research and Therapy

Volumn 16, Issue 2, 2014, Pages

  Woetzel, Dirk ^a   Huber, Rene ^b,c   Kupfer, Peter ^d   Pohlers, Dirk ^b,e   Pfaff, Michael ^a,f   Driesch, Dominik ^a   Häupl, Thomas ^g   Koczan, Dirk ^h   Stiehl, Peter ⁱ   Guthke, Reinhard ^d   Kinne, Raimund W ^b  

^a BIOCONTROL JENA GMBH   (Germany)

^b Jena University Hospital   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d HANS KNÖLL INSTITUTE   (Germany)

^e KLINIKUM CHEMNITZ   (Germany)

^f UNIVERSITY OF APPLIED SCIENCES JENA   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY OF ROSTOCK   (Germany)

ⁱ UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TRANSCRIPTOME; RNA;

ADULT; AGED; ARTICLE; CLASSIFIER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PREDICTIVE VALUE; RHEUMATOID ARTHRITIS; RULE BASED CLASSIFIER; SENSITIVITY AND SPECIFICITY; ARTHRITIS, RHEUMATOID; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; PROCEDURES; GENOME;

AGED; ARTHRITIS, RHEUMATOID; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOARTHRITIS; RNA; SENSITIVITY AND SPECIFICITY; TRANSCRIPTOME;

EID: 84900302734     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4526     Document Type: Article

References (131)

1. Murphy G, Nagase H. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?. Nat Clin Pract Rheumatol 2008, 4:128-135.
2. de Lange-Brokaar BJ, Ioan-Facsinay A, van Osch GJ, Zuurmond AM, Schoones J, Toes RE, Huizinga TW, Kloppenburg M. Synovial inflammation, immune cells and their cytokines in osteoarthritis: a review. Osteoarthritis Cartilage 2012, 20:1484-1499. 10.1016/j.joca.2012.08.027, 22960092.
3. Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology (Oxford) 2012, 51:v3-v11. 10.1093/rheumatology/kes113, 22718924.
4. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361. 10.1038/nature01661, 12748655.
5. Isaacs JD. The changing face of rheumatoid arthritis: sustained remission for all?. Nat Rev Immunol 2010, 10:605-611. 10.1038/nri2804, 20651747.
6. Rousseau JC, Delmas PD. Biological markers in osteoarthritis. Nat Clin Pract Rheumatol 2007, 3:346-356. 10.1038/ncprheum0508, 17538566.
7. Haseeb A, Haqqi TM. Immunopathogenesis of osteoarthritis. Clin Immunol 2013, 146:185-196. 10.1016/j.clim.2012.12.011, 23360836.
8. Reines BP. Is rheumatoid arthritis premature osteoarthritis with fetal-like healing?. Autoimmun Rev 2004, 3:305-311. 10.1016/j.autrev.2003.11.002, 15246027.
9. Schiff M, Peura D. HZT-501 (DUEXIS®; ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Expert Rev Gastroenterol Hepatol 2012, 6:25-35. 10.1586/egh.11.88, 22149579.
10. McCormack PL. Celecoxib: a review of its use for symptomatic relief in the treatment of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. Drugs 2011, 71:2457-2489. 10.2165/11208240-000000000-00000, 22141388.
11. Ravi B, Escott B, Shah PS, Jenkinson R, Chahal J, Bogoch E, Kreder H, Hawker G. A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. Arthritis Rheum 2012, 64:3839-3849. 10.1002/art.37690, 23192790.
12. Beasley J. Osteoarthritis and rheumatoid arthritis: conservative therapeutic management. J Hand Ther 2012, 25:163-171. 10.1016/j.jht.2011.11.001, 22326361.
13. Hashizume K, Nishida K, Fujiwara K, Kadota Y, Nakahara R, Ezawa K, Inoue H, Ozaki T. Radiographic measurements in the evaluation and classification of elbow joint destruction in patients with rheumatoid arthritis. Clin Rheumatol 2010, 29:637-643. 10.1007/s10067-010-1381-y, 20108011.
14. Krenn V, Morawietz L, Burmester GR, Kinne RW, Mueller-Ladner U, Muller B, Häupl T. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 2006, 49:358-364. 10.1111/j.1365-2559.2006.02508.x, 16978198.
15. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324. 10.1002/art.1780310302, 3358796.
16. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, Howell D, Kaplan D, Koopman W, Longley S, Mankin H, McShane DJ, Medsger T, Meenan R, Mikkelsen W, Moskowitz R, Murphy W, Rothschild B, Segal M, Sokoloff L, Wolfe F. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29:1039-1049. 10.1002/art.1780290816, 3741515.
17. Ross C. A comparison of osteoarthritis and rheumatoid arthritis: diagnosis and treatment. Nurse Pract 1997, 22:20-28.
18. Kunkel GA, Cannon GW, Clegg DO. Combined structural and synovial assessment for improved ultrasound discrimination of rheumatoid, osteoarthritic, and normal joints: a pilot study. Open Rheumatol J 2012, 6:199-206. 10.2174/1874312901206010199, 3419873, 22905071.
19. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010, 69:1580-1588. 10.1136/ard.2010.138461, 20699241.
20. Kennish L, Labitigan M, Budoff S, Filopoulos MT, McCracken WA, Swearingen CJ, Yazici Y. Utility of the new rheumatoid arthritis 2010 ACR/EULAR classification criteria in routine clinical care. BMJ Open 2012, 2:e001117. 3488748, 23035013.
21. van der Linden MP, Batstra MR, Bakker-Jonges LE, Detert J, Bastian H, Scherer HU, Toes RE, Burmester GR, Mjaavatten MD, Kvien TK, Huizinga TW, van der Helm-van Mil AH, . Foundation for Quality Medical Laboratory Diagnostics Toward a data-driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor?. Arthritis Rheum 2011, 63:1190-1199. 10.1002/art.30200, 21538311, Foundation for Quality Medical Laboratory Diagnostics.
22. van der Pouw Kraan TC, van Baarsen LG, Rustenburg F, Baltus B, Fero M, Verweij CL. Gene expression profiling in rheumatology. Methods Mol Med 2007, 136:305-327. 10.1007/978-1-59745-402-5_22, 17983157.
23. Lübbers J, Brink M, van de Stadt LA, Vosslamber S, Wesseling JG, van Schaardenburg D, Rantapää-Dahlqvist S, Verweij CL. The type I IFN signature as a biomarker of preclinical rheumatoid arthritis. Ann Rheum Dis 2013, 72:776-780. 10.1136/annrheumdis-2012-202753, 23434571.
24. Grcevic D, Jajic Z, Kovacic N, Lukic IK, Velagic V, Grubisic F, Ivcevic S, Marusic A. Peripheral blood expression profiles of bone morphogenetic proteins, tumor necrosis factor-superfamily molecules, and transcription factor Runx2 could be used as markers of the form of arthritis, disease activity, and therapeutic responsiveness. J Rheumatol 2010, 37:246-256. 10.3899/jrheum.090167, 20008919.
25. Mutlu N, Bicakcigil M, Tasan DA, Kaya A, Yavuz S, Ozden AI. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis. J Rheumatol 2009, 36:491-500. 10.3899/jrheum.080656, 19228660.
26. Kido A, Pap G, Kawate K, Roessner A, Takakura Y. Disease-specific expression patterns of proteases in synovial tissues. Pathol Res Pract 2007, 203:451-456. 10.1016/j.prp.2007.03.009, 17540510.
27. Bhattacharya S, Mariani TJ. Array of hope: expression profiling identifies disease biomarkers and mechanism. Biochem Soc Trans 2009, 37:855-862. 10.1042/BST0370855, 19614607.
28. van Baarsen LG, Bos CL, van der Pouw Kraan TC, Verweij CL. Transcription profiling of rheumatic diseases. Arthritis Res Ther 2009, 11:207. 10.1186/ar2557, 2688218, 19232067.
29. Lequerré T, Bansard C, Vittecoq O, Derambure C, Hiron M, Daveau M, Tron F, Ayral X, Biga N, Auquit-Auckbur I, Chiocchia G, Le Loët X, Salier JP. Early and long-standing rheumatoid arthritis: distinct molecular signatures identified by gene-expression profiling in synovia. Arthritis Res Ther 2009, 11:R99. 10.1186/ar2744, 2714155, 19563633.
30. Yi CQ, Ma CH, Xie ZP, Cao Y, Zhang GQ, Zhou XK, Liu ZQ. Comparative genome-wide gene expression analysis of rheumatoid arthritis and osteoarthritis. Genet Mol Res 2013, 12:3136-3145.
31. Li G, Han N, Li Z, Lu Q. Identification of transcription regulatory relationships in rheumatoid arthritis and osteoarthritis. Clin Rheumatol 2013, 32:609-615. 10.1007/s10067-012-2143-9, 23296645.
32. Raterman HG, Vosslamber S, de Ridder S, Nurmohamed MT, Lems WF, Boers M, van de Wiel M, Dijkmans BA, Verweij CL, Voskuyl AE. The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients. Arthritis Res Ther 2012, 14:R95. 10.1186/ar3819, 3446469, 22540992.
33. Stuhlmüller B, Häupl T, Hernandez MM, Grützkau A, Kuban RJ, Tandon N, Voss JW, Salfeld J, Kinne RW, Burmester GR. CD11c as a transcriptional biomarker to predict response to anti-TNF monotherapy with adalimumab in patients with rheumatoid arthritis. Clin Pharmacol Ther 2010, 87:311-321. 10.1038/clpt.2009.244, 20032971.
34. Glocker MO, Guthke R, Kekow J, Thiesen HJ. Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine. Med Res Rev 2006, 26:63-87. 10.1002/med.20045, 16283676.
35. Sha N, Vannucci M, Brown PJ, Trower MK, Amphlett G, Falciani F. Gene selection in arthritis classification with large-scale microarray expression profiles. Comp Funct Genomics 2003, 4:171-181. 10.1002/cfg.264, 2447416, 18629129.
36. Quinlan JR. Induction of decision trees. Mach Learn 1986, 1:81-106.
37. Simon S, Guthke R, Kamradt T, Frey O. Multivariate analysis of flow cytometric data using decision trees. Front Microbio 2012, 3:114.
38. Guthke R, Schmidt-Heck W, Pfaff M. Knowledge acquisition and knowledge based control in bioprocess engineering. J Biotechnol 1998, 65:37-46.
39. Troschke SO. Kennzahlen der regelbasierten Modellierung in Experten systemen. Ein Ansatz zur Bewertung von Unsicherheit bei der automatischen Erzeugung von Produktionsregeln. Diploma thesis 1992, Chair of Electrical Control Engineering, University of Dortmund, Germany.
40. Krone A, Kiendl H. Automatic generation of positive and negative rules for two-way fuzzy controllers. Proceedings of the Second European Congress on Intelligent Techniques and Soft Computing, EUFIT '94 1994, 438-447. Aachen (Germany).
41. Krabs M, Kiendl H. Anwendungsfelder der automatischen Regelgenerierung mit dem ROSA Verfahren. Automatisierungstechnik 1995, 43:269-276.
42. Jessen H, Slawinski T. Test and rating strategies for data based rule generation. Computational Intelligence, Sonderforschungsbereich 531 1998, Dortmund: German National Library of Science and Technology (TIB), Hannover, Germany, Paper No. CI-39/98, http://hdl.handle.net/10068/240405.
43. Kiendl H, Krause P, Schauten D, Slawinski T. Data-based fuzzy modeling for complex applications. Advance in Computational Intelligence: Theory and Practice (Natural Computing Series) 2003, 46-77. Heidelberg, Germany: Springer, Schwefel H-P, Wegener I, Weinert KD.
44. Huber R, Kunisch E, Glück B, Egerer R, Sickinger S, Kinne RW. Comparison of conventional and real-time RT-PCR for the quantitation of jun protooncogene mRNA and analysis of junB mRNA expression in synovial membranes and isolated synovial fibroblasts from rheumatoid arthritis patients. Z Rheumatol 2003, 62:378-389. 10.1007/s00393-003-0472-4, 12928942.
45. Chen C, Grennan K, Badner J, Zhang D, Gershon E, Jin L, Liu C. Removing batch effects in analysis of expression microarray data: an evaluation of six batch adjustment methods. PLoS One 2011, 6:e17238. 10.1371/journal.pone.0017238, 3046121, 21386892.
46. Bezdek JC, Pal SK. Fuzzy Models for Pattern Recognition: Methods that Search for Structures in Data 1992, New York: IEEE Press.
47. Huang DW, Sherman BT, Tan Q, Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC, Lempicki RA. DAVID Bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 2007, 35:W169-W175. 10.1093/nar/gkm415, 1933169, 17576678.
48. Briken V, Ruffner H, Schultz U, Schwarz A, Reis LF, Strehlow I, Decker T, Staeheli P. Interferon regulatory factor 1 is required for mouse Gbp gene activation by gamma interferon. Mol Cell Biol 1995, 15:975-982. 231988, 7823961.
49. Ni Z, Karaskov E, Yu T, Callaghan SM, Der S, Park DS, Xu Z, Pattenden SG, Bremner R. Apical role for BRG1 in cytokine-induced promoter assembly. Proc Natl Acad Sci USA 2005, 102:14611-14616. 10.1073/pnas.0503070102, 1253546, 16195385.
50. Snyder M, He W, Zhang JJ. The DNA replication factor MCM5 is essential for Stat1-mediated transcriptional activation. Proc Natl Acad Sci USA 2005, 102:14539-14544. 10.1073/pnas.0507479102, 1253610, 16199513.
51. Zhao Y, Wagner F, Frank SJ, Kraft AS. The amino-terminal portion of the JAK2 protein kinase is necessary for binding and phosphorylation of the granulocyte-macrophage colony-stimulating factor receptor beta c chain. J Biol Chem 1995, 270:13814-13818. 10.1074/jbc.270.23.13814, 7775438.
52. Rane SG, Reddy EP. JAKs, STATs and Src kinases in hematopoiesis. Oncogene 2002, 21:3334-3358. 10.1038/sj.onc.1205398, 12032773.
53. Reddy EP, Korapati A, Chaturvedi P, Rane S. IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled. Oncogene 2000, 19:2532-2547. 10.1038/sj.onc.1203594, 10851052.
54. Reichelt O, Müller J, von Eggeling F, Driesch D, Wunderlich H, Schubert J, Gröne HJ, Stein G, Ott U, Junker K. Prediction of renal allograft rejection by urinary protein analysis using ProteinChip arrays (surface-enhanced laser desorption/ionization time-of-flight mass spectrometry). Urology 2006, 67:472-475. 10.1016/j.urology.2005.09.038, 16527560.
55. Driesch D, Wötzel D, Guthke R, Pfaff M. Fuzzy cluster and fuzzy rule cancer status prediction based on gene expression data. Proceedings of the 4th International Workshop on Biosignal Interpretation 2002, 7-10. Como, Italy: Schattauer, Stuttgart, Germany, Cerutti S.
56. Ruschpler P, Lorenz P, Eichler W, Koczan D, Hänel H, Scholz R, Melzer C, Thiesen HJ, Stiehl P. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res Ther 2003, 5:R241. 10.1186/ar783, 193722, 12932287.
57. Biswas S, Manikandan J, Pushparaj PN. Decoding the differential biomarkers of Rheumatoid arthritis and Osteoarthritis: a functional genomics paradigm to design disease specific therapeutics. Bioinformation 2011, 6:153-157. 10.6026/97320630006153, 3092949, 21572882.
58. Xue F, Zhang C, He Z, Ding L, Xiao H. Analysis of critical molecules and signaling pathways in osteoarthritis and rheumatoid arthritis. Mol Med Rep 2013, 7:603-607.
59. Yoshida S, Arakawa F, Higuchi F, Ishibashi Y, Goto M, Sugita Y, Nomura Y, Niino D, Shimizu K, Aoki R, Hashikawa K, Kimura Y, Yasuda K, Tashiro K, Kuhara S, Nagata K, Ohshima K. Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5. Scand J Rheumatol 2012, 41:170-179. 10.3109/03009742.2011.623137, 3400100, 22401175.
60. van der Pouw Kraan TC, van Gaalen FA, Kasperkovitz PV, Verbeet NL, Smeets TJ, Kraan MC, Fero M, Tak PP, Huizinga TW, Pieterman E, Breedveld FC, Alizadeh AA, Verweij CL. Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum 2003, 48:2132-2145. 10.1002/art.11096, 12905466.
61. Zhang W, Zhang J, Kornuc M, Kwan K, Frank R, Nimer SD. Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter. Mol Cell Biol 1995, 15:6055-6063. 230857, 7565758.
62. Monnier V, Iché-Torres M, Rera M, Contremoulins V, Guichard C, Lalevée N, Tricoire H, Perrin L. dJun and Vri/dNFIL3 are major regulators of cardiac aging in Drosophila. PLoS Genet 2012, 8:e1003081. 10.1371/journal.pgen.1003081, 3510041, 23209438.
63. Smith AM, Qualls JE, O'Brien K, Balouzian L, Johnson PF, Schultz-Cherry S, Smale ST, Murray PJ. A distal enhancer in Il12b is the target of transcriptional repression by the STAT3 pathway and requires the basic leucine zipper (B-ZIP) protein NFIL3. J Biol Chem 2011, 286:23582-23590. 10.1074/jbc.M111.249235, 3123121, 21566115.
64. Kobayashi T, Matsuoka K, Sheikh SZ, Elloumi HZ, Kamada N, Hisamatsu T, Hansen JJ, Doty KR, Pope SD, Smale ST, Hibi T, Rothman PB, Kashiwada M, Plevy SE. NFIL3 is a regulator of IL-12 p40 in macrophages and mucosal immunity. J Immunol 2011, 186:4649-4655. 10.4049/jimmunol.1003888, 3172700, 21383239.
65. Kashiwada M, Cassel SL, Colgan JD, Rothman PB. NFIL3/E4BP4 controls type 2 T helper cell cytokine expression. EMBO J 2011, 30:2071-2082. 10.1038/emboj.2011.111, 3098483, 21499227.
66. Kamizono S, Duncan GS, Seidel MG, Morimoto A, Hamada K, Grosveld G, Akashi K, Lind EF, Haight JP, Ohashi PS, Look AT, Mak TW. Nfil3/E4bp4 is required for the development and maturation of NK cells in vivo. J Exp Med 2009, 206:2977-2986. 10.1084/jem.20092176, 2806474, 19995955.
67. Cowell IG. E4BP4/NFIL3, a PAR-related bZIP factor with many roles. Bioessays 2002, 24:1023-1029. 10.1002/bies.10176, 12386933.
68. Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 2001, 20:2390-2400. 10.1038/sj.onc.1204383, 11402335.
69. Kogut MH, Genovese KJ, He H, Kaiser P. Flagellin and lipopolysaccharide up-regulation of IL-6 and CXCLi2 gene expression in chicken heterophils is mediated by ERK1/2-dependent activation of AP-1 and NF-kappaB signaling pathways. Innate Immun 2008, 14:213-222. 10.1177/1753425908094416, 18669607.
70. Weitzman JB, Fiette L, Matsuo K, Yaniv M. JunD protects cells from p53-dependent senescence and apoptosis. Mol Cell 2000, 6:1109-1119. 10.1016/S1097-2765(00)00109-X, 11106750.
71. Mineva ND, Rothstein TL, Meyers JA, Lerner A, Sonenshein GE. CD40 ligand-mediated activation of the de novo RelB NF-kappaB synthesis pathway in transformed B cells promotes rescue from apoptosis. J Biol Chem 2007, 282:17475-17485. 10.1074/jbc.M607313200, 17446175.
72. Zerbini LF, de Vasconcellos JF, Czibere A, Wang Y, Paccez JD, Gu X, Zhou JR, Libermann TA. JunD-mediated repression of GADD45α and γ regulates escape from cell death in prostate cancer. Cell Cycle 2011, 10:2583-2591. 10.4161/cc.10.15.16057, 3180197, 21734453.
73. Schutte J, Viallet J, Nau M, Segal S, Fedorko J, Minna J. Jun-B inhibits and c-fos stimulates the transforming and trans-activating activities of c-jun. Cell 1989, 59:987-997. 10.1016/0092-8674(89)90755-1, 2513129.
74. Morita Y, Kashihara N, Yamamura M, Okamoto H, Harada S, Kawashima M, Makino H. Antisense oligonucleotides targeting c-fos mRNA inhibit rheumatoid synovial fibroblast proliferation. Ann Rheum Dis 1998, 57:122-124. 10.1136/ard.57.2.122, 1752536, 9613344.
75. White LA, Brinckerhoff CE. Two activator protein-1 elements in the matrix metalloproteinase-1 promoter have different effects on transcription and bind Jun D, c-Fos, and Fra-2. Matrix Biol 1995, 14:715-725. 10.1016/S0945-053X(05)80014-9, 8785586.
76. Castellazzi M, Spyrou G, La Vista N, Dangy JP, Piu F, Yaniv M, Brun G. Overexpression of c-jun, junB, or junD affects cell growth differently. Proc Natl Acad Sci U S A 1991, 88:8890-8894. 10.1073/pnas.88.20.8890, 52616, 1924349.
77. Wakisaka S, Suzuki N, Saito N, Ochi T, Sakane T. Possible correction of abnormal rheumatoid arthritis synovial cell function by jun D transfection in vitro. Arthritis Rheum 1998, 41:470-481. 10.1002/1529-0131(199803)41:3<470::AID-ART14>3.0.CO;2-O, 9506576.
78. Bakiri L, Matsuo K, Wisniewska M, Wagner EF, Yaniv M. Promoter specificity and biological activity of tethered AP-1 dimers. Mol Cell Biol 2002, 22:4952-4964. 10.1128/MCB.22.13.4952-4964.2002, 133900, 12052899.
79. Cuevas BD, Uhlik MT, Garrington TP, Johnson GL. MEKK1 regulates the AP-1 dimer repertoire via control of JunB transcription and Fra-2 protein stability. Oncogene 2005, 24:801-809. 10.1038/sj.onc.1208239, 15558021.
80. Tomasi ML, Ryoo M, Skay A, Tomasi I, Giordano P, Mato JM, Lu SC. Polyamine and methionine adenosyltransferase 2A crosstalk in human colon and liver cancer. Exp Cell Res 2013, 319:1902-1911. 10.1016/j.yexcr.2013.04.005, 23588207.
81. Amé JC, Spenlehauer C, de Murcia G. The PARP superfamily. Bioessays 2004, 26:882-893. 10.1002/bies.20085, 15273990.
82. Ma Q, Baldwin KT, Renzelli AJ, McDaniel A, Dong L. TCDDinducible poly(ADP-ribose) polymerase: a novel response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Biophys Res Commun 2001, 289:499-506. 10.1006/bbrc.2001.5987, 11716501.
83. Bailleul B, Akerblom I, Strosberg AD. The leptin receptor promoter controls expression of a second distinct protein. Nucleic Acids Res 1997, 25:2752-2758. 10.1093/nar/25.14.2752, 146799, 9207021.
84. Huang Y, Ying K, Xie Y, Zhou Z, Wang W, Tang R, Zhao W, Zhao S, Wu H, Gu S, Mao Y. Cloning and characterization of a novel human leptin receptor overlapping transcript-like 1 gene (LEPROTL1). Biochim Biophys Acta 2001, 1517:327-331. 10.1016/S0167-4781(00)00266-9, 11342119.
85. Belgareh-Touze N, Avaro S, Rouille Y, Hoflack B, Haguenauer-Tsapis R. Yeast Vps55p, a functional homolog of human obesity receptor gene-related protein, is involved in late endosome to vacuole trafficking. Mol Biol Cell 2002, 13:1694-1708. 10.1091/mbc.01-12-0597, 111137, 12006663.
86. Mercer JG, Moar KM, Hoggard N, Strosberg AD, Froguel P, Bailleul B. B219/OB-R 5′-UTR and leptin receptor gene-related protein gene expression in mouse brain and placenta: tissue-specific leptin receptor promoter activity. J Neuroendocrinol 2000, 12:649-655.
87. Touvier T, Conte-Auriol F, Briand O, Cudejko C, Paumelle R, Caron S, Baugé E, Rouillé Y, Salles JP, Staels B, Bailleul B. LEPROT and LEPROTL1 cooperatively decrease hepatic growth hormone action in mice. J Clin Invest 2009, 119:3830-3838. 10.1172/JCI34997, 2786784, 19907080.
88. Couturier C, Sarkis C, Séron K, Belouzard S, Chen P, Lenain A, Corset L, Dam J, Vauthier V, Dubart A, Mallet J, Froguel P, Rouillé Y, Jockers R. Silencing of OB-RGRP in mouse hypothalamic arcuate nucleus increases leptin receptor signaling and prevents diet-induced obesity. Proc Natl Acad Sci USA 2007, 104:19476-19481. 10.1073/pnas.0706671104, 2148314, 18042720.
89. Weissmann G. The mediation of rheumatoid inflammation by lysosomes. Adv Clin Pharmacol 1974, 6:51-63.
90. Bitensky L, Butcher RG, Johnstone JJ, Chayen J. Effect of glucocorticoids on lysosomes in synovial lining cells in human rheumatoid arthritis. Ann Rheum Dis 1974, 33:57-61. 10.1136/ard.33.1.57, 1006200, 4362491.
91. Lockwood TD. The lysosome among targets of metformin: new anti-inflammatory uses for an old drug?. Expert Opin Ther Targets 2010, 14:467-478. 10.1517/14728221003774135, 20392164.
92. Wollbold J, Huber R, Pohlers D, Koczan D, Guthke R, Kinne RW, Gausmann U. Adapted Boolean network models for extracellular matrix formation. BMC Syst Biol 2009, 3:77. 10.1186/1752-0509-3-77, 2734845, 19622164.
93. Ivashkiv LB, Hu X. The JAK/STAT pathway in rheumatoid arthritis: pathogenic or protective?. Arthritis Rheum 2003, 48:2092-2096. 10.1002/art.11095, 12905460.
94. Okamoto H, Cujec TP, Yamanaka H, Kamatani N. Molecular aspects of rheumatoid arthritis: role of transcription factors. FEBS J 2008, 275:4463-4470. 10.1111/j.1742-4658.2008.06582.x, 18662303.
95. Devauchelle V, Marion S, Cagnard N, Mistou S, Falgarone G, Breban M, Letourneur F, Pitaval A, Alibert O, Lucchesi C, Anract P, Hamadouche M, Ayral X, Dougados M, Gidrol X, Fournier C, Chiocchia G. DNA microarray allows molecular profiling of rheumatoid arthritis and identification of pathophysiological targets. Genes Immun 2004, 5:597-608. 10.1038/sj.gene.6364132, 15496955.
96. Kasperkovitz PV, Timmer TC, Smeets TJ, Verbeet NL, Tak PP, van Baarsen LG, Baltus B, Huizinga TW, Pieterman E, Fero M, Firestein GS, van der Pouw Kraan TC, Verweij CL. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis. Arthritis Rheum 2005, 52:430-441. 10.1002/art.20811, 15692990.
97. Früh K, Yang Y. Antigen presentation by MHC class I and its regulation by interferon gamma. Curr Opin Immunol 1999, 11:76-81. 10.1016/S0952-7915(99)80014-4, 10047537.
98. Ebstein F, Kloetzel PM, Krüger E, Seifert U. Emerging roles of immunoproteasomes beyond MHC class I antigen processing. Cell Mol Life Sci 2012, 69:2543-2558. 10.1007/s00018-012-0938-0, 22382925.
99. Yu L, Li Q, Lin J, Yu J, Li Q, Yi W, Sun H, Chu JY, Yang ZQ. Association between polymorphisms of PSMB8, PSMB9 and TAP2 genes with rheumatoid arthritis in ethnic Han Chinese from Yunnan. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (Chin Med Genet) 2013, 30:222-226.
100. Scheffler S, Kuckelkorn U, Egerer K, Dörner T, Reiter K, Soza A, Burmester GR, Feist E. Autoimmune reactivity against the 20S-proteasome includes immunosubunits LMP2 (beta1i), MECL1 (beta2i) and LMP7 (beta5i). Rheumatology 2008, 47:622-626. 10.1093/rheumatology/ken042, 18375405.
101. Yu P, Constien R, Dear N, Katan M, Hanke P, Bunney TD, Kunder S, Quintanilla-Martinez L, Huffstadt U, Schröder A, Jones NP, Peters T, Fuchs H, de Angelis MH, Nehls M, Grosse J, Wabnitz P, Meyer TP, Yasuda K, Schiemann M, Schneider-Fresenius C, Jagla W, Russ A, Popp A, Josephs M, Marquardt A, Laufs J, Schmittwolf C, Wagner H, Pfeffer K, et al. Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry. Immunity 2005, 22:451-465. 10.1016/j.immuni.2005.01.018, 15845450.
102. Abe K, Fuchs H, Boersma A, Hans W, Yu P, Kalaydjiev S, Klaften M, Adler T, Calzada-Wack J, Mossbrugger I, Rathkolb B, Rozman J, Prehn C, Maraslioglu M, Kametani Y, Shimada S, Adamski J, Busch DH, Esposito I, Klingenspor M, Wolf E, Wurst W, Gailus-Durner V, Katan M, Marschall S, Soewarto D, Wagner S, de Angelis MH. A novel N-ethyl-N-nitrosourea-induced mutation in phospholipase Cγ2 causes inflammatory arthritis, metabolic defects, and male infertility in vitro in a murine model. Arthritis Rheum 2011, 63:1301-1311. 10.1002/art.30280, 21305534.
103. Marco de Leon J. Gene Expression Profiling of Multiple Autoimmune Diseases 2008, Ann Arbor, MI: ProQuest LLC, University of Minnesota Epidemiology Microform.
104. Array express Transcription profiling of human synovial samples from patients with osteoarthritis, rheumatoid arthritis vs controls treated with various drug regimes to characterise RA at the molecular level and to uncover key pathomechanisms Hinxton, Cambridge CB10 1SD, United Kingdom: The EMBL-European Bioinformatics Institute Wellcome Trust Genome Campus, [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-1919/], Array express.
105. Kato M, Neil TK, Clark GJ, Morris CM, Sorg RV, Hart DN. cDNA cloning of human DEC-205, a putative antigen-uptake receptor on dendritic cells. Immunogenetics 1998, 47:442-450. 10.1007/s002510050381, 9553150.
106. McKay PF, Imami N, Johns M, Taylor-Fishwick DA, Sedibane LM, Totty NF, Hsuan JJ, Palmer DB, George AJ, Foxwell BM, Ritter MA. The gp200-MR6 molecule which is functionally associated with the IL-4 receptor modulates B cell phenotype and is a novel member of the human macrophage mannose receptor family. Eur J Immunol 1998, 28:4071-4083. 10.1002/(SICI)1521-4141(199812)28:12<4071::AID-IMMU4071>3.0.CO;2-O, 9862343.
107. Array express E-GEOD-38351 - The multifaceted balance of TNF-a and type I / II interferon responses in SLE and RA: how monocytes manage the impact of cytokines. Hinxton, Cambridge CB10 1SD, United Kingdom: The EMBL-European Bioinformatics Institute Wellcome Trust Genome Campus, [http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-38351/], Array express.
108. Greenawalt DM, Sieberts SK, Cornelis MC, Girman CJ, Zhong H, Yang X, Guinney J, Qi L, Hu FB. Integrating genetic association, genetics of gene expression, and single nucleotide polymorphism set analysis to identify susceptibility Loci for type 2 diabetes mellitus. Am J Epidemiol 2012, 176:423-430. 10.1093/aje/kws123, 3499116, 22865700.
109. Wang X, Lupardus P, Laporte SL, Garcia KC. Structural biology of shared cytokine receptors. Annu Rev Immunol 2009, 27:29-60. 10.1146/annurev.immunol.24.021605.090616, 3981547, 18817510.
110. Hansen G, Hercus TR, McClure BJ, Stomski FC, Dottore M, Powell J, Ramshaw H, Woodcock JM, Xu Y, Guthridge M, McKinstry WJ, Lopez AF, Parker MW. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell 2008, 134:496-507. 10.1016/j.cell.2008.05.053, 18692472.
111. Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J Clin Invest 1990, 86:1790-1798. 10.1172/JCI114908, 329810, 2174906.
112. Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Cytokines in chronic inflammatory arthritis. IV. Granulocyte/macrophage colony-stimulating factor-mediated induction of class II MHC antigen on human monocytes: a possible role in rheumatoid arthritis. J Exp Med 1989, 170:865-875. 10.1084/jem.170.3.865, 2189430, 2504878.
113. Xu WD, Firestein GS, Taetle R, Kaushansky K, Zvaifler NJ. Cytokines in chronic inflammatory arthritis. II. Granulocyte-macrophage colony-stimulating factor in rheumatoid synovial effusions. J Clin Invest 1989, 83:876-882. 10.1172/JCI113971, 303761, 2646320.
114. Wang Y, Thomson CA, Allan LL, Jackson LM, Olson M, Hercus TR, Nero TL, Turner A, Parker MW, Lopez AL, Waddell TK, Anderson GP, Hamilton JA, Schrader JW. Characterization of pathogenic human monoclonal autoantibodies against GM-CSF. Proc Natl Acad Sci U S A 2013, 110:7832-7837. 10.1073/pnas.1216011110, 3651501, 23620516.
115. Tuller T, Atar S, Ruppin E, Gurevich M, Achiron A. Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases. Genes Immun 2013, 14:67-82. 10.1038/gene.2012.55, 23190644.
116. Tenti S, Correale P, Conca R, Pastina P, Fioravanti A. Occurrence of Sjögren syndrome in a long-term survivor patient with metastatic colon carcinoma treated with GOLFIG regimen. J Chemother 2012, 24:245-246.
117. Cook AD, Pobjoy J, Steidl S, Dürr M, Braine EL, Turner AL, Lacey DC, Hamilton JA. Granulocyte-macrophage colony-stimulating factor is a key mediator in experimental osteoarthritis pain and disease development. Arthritis Res Ther 2012, 14:R199. 10.1186/ar4037, 3580511, 22995428.
118. Zhang W, Cong XL, Qin YH, He ZW, He DY, Dai SM. IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis. Inflammation 2013, 36:103-109. 10.1007/s10753-012-9524-8, 22945280.
119. Hughes-Austin JM, Deane KD, Derber LA, Kolfenbach JR, Zerbe GO, Sokolove J, Lahey LJ, Weisman MH, Buckner JH, Mikuls TR, O'Dell JR, Keating RM, Gregersen PK, Robinson WH, Holers VM, Norris JM. Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis 2013, 72:901-907. 10.1136/annrheumdis-2012-201505, 22915618.
120. Minter RR, Cohen ES, Wang B, Liang M, Vainshtein I, Rees G, Eghobamien L, Harrison P, Sims DA, Matthews C, Wilkinson T, Monk P, Drinkwater C, Fabri L, Nash A, McCourt M, Jermutus L, Roskos L, Anderson IK, Sleeman MA. Protein engineering and preclinical development of a GM-CSF receptor antibody for the treatment of rheumatoid arthritis. Br J Pharmacol 2013, 168:200-211. 10.1111/j.1476-5381.2012.02173.x, 3570015, 22913645.
121. Nair JR, Edwards SW, Moots RJ. Mavrilimumab, a human monoclonal GM-CSF receptor-α antibody for the management of rheumatoid arthritis: a novel approach to therapy. Expert Opin Biol Ther 2012, 12:1661-1668. 10.1517/14712598.2012.732062, 23094973.
122. Burmester GR, Weinblatt ME, McInnes IB, Porter D, Barbarash O, Vatutin M, Szombati I, Esfandiari E, Sleeman MA, Kane CD, Cavet G, Wang B, Godwood A, Magrini F, . EARTH Study Group Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Ann Rheum Dis 2013, 72:1445-1452. 10.1136/annrheumdis-2012-202450, 3756523, 23234647, EARTH Study Group.
123. Kuramochi S, Moriguchi T, Kuida K, Endo J, Semba K, Nishida E, Karasuyama H. LOK is a novel mouse STE20-like protein kinase that is expressed predominantly in lymphocytes. J Biol Chem 1997, 272:22679-22684. 10.1074/jbc.272.36.22679, 9278426.
124. Tao L, Wadsworth S, Mercer J, Mueller C, Lynn K, Siekierka J, August A. Opposing roles of serine/threonine kinases MEKK1 and LOK in regulating the CD28 responsive element in T-cells. Biochem J 2002, 363:175-182. 10.1042/0264-6021:3630175, 1222464, 11903060.
125. Belkina NV, Liu Y, Hao JJ, Karasuyama H, Shaw S. LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation. Proc Natl Acad Sci U S A 2009, 106:4707-4712. 10.1073/pnas.0805963106, 2660762, 19255442.
126. Fukumura K, Yamashita Y, Kawazu M, Sai E, Fujiwara S, Nakamura N, Takeuchi K, Ando M, Miyazono K, Ueno T, Ozawa K, Mano H. STK10 missense mutations associated with anti-apoptotic function. Oncol Rep 2013, 30:1542-1548.
127. Korb A, Pavenstädt H, Pap T. Cell death in rheumatoid arthritis. Apoptosis 2009, 14:447-454. 10.1007/s10495-009-0317-y, 19199037.
128. Yamamoto N, Honma M, Suzuki H. Off-target serine/threonine kinase 10 inhibition by erlotinib enhances lymphocytic activity leading to severe skin disorders. Mol Pharmacol 2011, 80:466-475. 10.1124/mol.110.070862, 21606217.
129. Seavey MM, Dobrzanski P. The many faces of Janus kinase. Biochem Pharmacol 2012, 83:1136-1145. 10.1016/j.bcp.2011.12.024, 22209716.
130. Malemud CJ. Differential activation of JAK enzymes in rheumatoid arthritis and autoimmune disorders by pro-inflammatory cytokines: potential drug targets. Int J Infereron Cytokine Mediator Res 2010, 2:97-111.
131. O'Shea JJ, Plenge R. JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity 2012, 36:542-550. 10.1016/j.immuni.2012.03.014, 3499974, 22520847.